Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune ...
AMPLIFY, a boutique legal marketing and PR agency, is proud to announce its role as an Event Sponsor for the 2026 Palm Beach ...
Done right, video depositions can be powerful evidence, locking in key admissions or juicy details. Videotaped depositions are much more than just perfunctory stepping stones on your path through the ...
AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
36m
A Chinese official exposed his boss. Now in Texas, he’s hunted by Beijing - with help from US tech
Retired Chinese official Li Chuanliang fled to the U.S. seeking asylum, fearing persecution from the Chinese government. He ...
An international hub for research and information about Alzheimer’s and other forms of dementia will get a new home because ...
The case was dismissed Friday against a man who spent a quarter-century on death row for the robbery and murder of a New ...
Thai and Cambodian leaders have agreed to renew a ceasefire after days of deadly clashes, Trump says
President Donald Trump said on Friday that Thai and Cambodian leaders have agreed to renew a ceasefire after days of deadly ...
It strengthened the impression that the fortunes of Democrats rise every day Donald Trump is president. It also showed how ...
The first patient visit has taken place for the SURMOUNT-REAL UK clinical trial of Eli Lilly and Company’s weight-loss drug, tirzepatide.
As Burger King poured hundreds of millions into its “Reclaim the Flame” plan, much of the attention, understandably, diverted ...
GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback